NCT02057380 2024-11-20A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib TrialAstellas Pharma IncPhase 2 Completed13 enrolled
NCT00064636 2005-06-24Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsMillennium Pharmaceuticals, Inc.Phase 1 Terminated46 enrolled